Over 20 years of treatment-free remission after interferon-alpha monotherapy for chronic myeloid leukemia

Leuk Res. 2018 Oct:73:103-104. doi: 10.1016/j.leukres.2018.09.002. Epub 2018 Sep 11.

Authors

Jonathan Bloch¹, Olivier Spertini², Anne Stucki³, Francoise Solly², Sabine Blum²

Affiliations

¹ Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Lausanne, Switzerland. Electronic address: [email protected].
² Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
³ Private Practice Lausanne, Switzerland.

PMID: 30261456
DOI: 10.1016/j.leukres.2018.09.002

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Humans
Interferon-alpha / administration & dosage*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Male
Remission Induction*

Substances

Interferon-alpha